SLAMF6 in health and disease: Implications for therapeutic targeting
•SLAMF6 is a cell surface receptor, expressed only on hematopoietic cells•SLAMF6 receptor can positively or negatively regulate immune responses•SLAMF6 is implicated in autoimmunity and cancer and this receptor can be targeted to help improve current treatment in various diseases.
Gespeichert in:
| Veröffentlicht in: | Clinical immunology (Orlando, Fla.) Fla.), 2019-07, Vol.204, p.3-13 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 13 |
|---|---|
| container_issue | |
| container_start_page | 3 |
| container_title | Clinical immunology (Orlando, Fla.) |
| container_volume | 204 |
| creator | Yigit, Burcu Wang, Ninghai Herzog, Roland W. Terhorst, Cox |
| description | •SLAMF6 is a cell surface receptor, expressed only on hematopoietic cells•SLAMF6 receptor can positively or negatively regulate immune responses•SLAMF6 is implicated in autoimmunity and cancer and this receptor can be targeted to help improve current treatment in various diseases. |
| doi_str_mv | 10.1016/j.clim.2018.10.013 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2126908547</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1521661618304042</els_id><sourcerecordid>2126908547</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-29c2761dc0179ddd6177a8841366ff1cc6143daec80c3615867680beecd478fb3</originalsourceid><addsrcrecordid>eNp9kEtPwzAQhC0EouXxBzigHLk07DqJkyIuVaFQqYgDcLZce9O6yqPYLhL_nkQtHDntajQz2v0Yu0KIEVDcbmJd2TrmgEUnxIDJERtixnGUQ5IdH3YhUAzYmfcbAMg4F6dskEDSySCG7OFtMXmZicg20ZpUFdaRakxkrCfl6S6a19vKahVs2_iobF0U1uTUlnbB6igot6Jgm9UFOylV5enyMM_Zx-zxffo8Wrw-zaeTxUinAGHEx5rnAo0GzMfGGIF5rooixe6YskStBaaJUaQL0InArBC5KGBJpE2aF-UyOWc3-96taz935IOsrddUVaqhduclRy7GUGRp3ln53qpd672jUm6drZX7lgiypyc3sqcne3q91tHrQteH_t2yJvMX-cXVGe73Buq-_LLkpNeWGk3GOtJBmtb-1_8D2ot_Hg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2126908547</pqid></control><display><type>article</type><title>SLAMF6 in health and disease: Implications for therapeutic targeting</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Yigit, Burcu ; Wang, Ninghai ; Herzog, Roland W. ; Terhorst, Cox</creator><creatorcontrib>Yigit, Burcu ; Wang, Ninghai ; Herzog, Roland W. ; Terhorst, Cox</creatorcontrib><description>•SLAMF6 is a cell surface receptor, expressed only on hematopoietic cells•SLAMF6 receptor can positively or negatively regulate immune responses•SLAMF6 is implicated in autoimmunity and cancer and this receptor can be targeted to help improve current treatment in various diseases.</description><identifier>ISSN: 1521-6616</identifier><identifier>EISSN: 1521-7035</identifier><identifier>DOI: 10.1016/j.clim.2018.10.013</identifier><identifier>PMID: 30366106</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Humans ; Neoplasms - immunology ; Signaling Lymphocytic Activation Molecule Family - immunology</subject><ispartof>Clinical immunology (Orlando, Fla.), 2019-07, Vol.204, p.3-13</ispartof><rights>2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-29c2761dc0179ddd6177a8841366ff1cc6143daec80c3615867680beecd478fb3</citedby><cites>FETCH-LOGICAL-c400t-29c2761dc0179ddd6177a8841366ff1cc6143daec80c3615867680beecd478fb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.clim.2018.10.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30366106$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yigit, Burcu</creatorcontrib><creatorcontrib>Wang, Ninghai</creatorcontrib><creatorcontrib>Herzog, Roland W.</creatorcontrib><creatorcontrib>Terhorst, Cox</creatorcontrib><title>SLAMF6 in health and disease: Implications for therapeutic targeting</title><title>Clinical immunology (Orlando, Fla.)</title><addtitle>Clin Immunol</addtitle><description>•SLAMF6 is a cell surface receptor, expressed only on hematopoietic cells•SLAMF6 receptor can positively or negatively regulate immune responses•SLAMF6 is implicated in autoimmunity and cancer and this receptor can be targeted to help improve current treatment in various diseases.</description><subject>Animals</subject><subject>Humans</subject><subject>Neoplasms - immunology</subject><subject>Signaling Lymphocytic Activation Molecule Family - immunology</subject><issn>1521-6616</issn><issn>1521-7035</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtPwzAQhC0EouXxBzigHLk07DqJkyIuVaFQqYgDcLZce9O6yqPYLhL_nkQtHDntajQz2v0Yu0KIEVDcbmJd2TrmgEUnxIDJERtixnGUQ5IdH3YhUAzYmfcbAMg4F6dskEDSySCG7OFtMXmZicg20ZpUFdaRakxkrCfl6S6a19vKahVs2_iobF0U1uTUlnbB6igot6Jgm9UFOylV5enyMM_Zx-zxffo8Wrw-zaeTxUinAGHEx5rnAo0GzMfGGIF5rooixe6YskStBaaJUaQL0InArBC5KGBJpE2aF-UyOWc3-96taz935IOsrddUVaqhduclRy7GUGRp3ln53qpd672jUm6drZX7lgiypyc3sqcne3q91tHrQteH_t2yJvMX-cXVGe73Buq-_LLkpNeWGk3GOtJBmtb-1_8D2ot_Hg</recordid><startdate>201907</startdate><enddate>201907</enddate><creator>Yigit, Burcu</creator><creator>Wang, Ninghai</creator><creator>Herzog, Roland W.</creator><creator>Terhorst, Cox</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201907</creationdate><title>SLAMF6 in health and disease: Implications for therapeutic targeting</title><author>Yigit, Burcu ; Wang, Ninghai ; Herzog, Roland W. ; Terhorst, Cox</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-29c2761dc0179ddd6177a8841366ff1cc6143daec80c3615867680beecd478fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Humans</topic><topic>Neoplasms - immunology</topic><topic>Signaling Lymphocytic Activation Molecule Family - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yigit, Burcu</creatorcontrib><creatorcontrib>Wang, Ninghai</creatorcontrib><creatorcontrib>Herzog, Roland W.</creatorcontrib><creatorcontrib>Terhorst, Cox</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical immunology (Orlando, Fla.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yigit, Burcu</au><au>Wang, Ninghai</au><au>Herzog, Roland W.</au><au>Terhorst, Cox</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SLAMF6 in health and disease: Implications for therapeutic targeting</atitle><jtitle>Clinical immunology (Orlando, Fla.)</jtitle><addtitle>Clin Immunol</addtitle><date>2019-07</date><risdate>2019</risdate><volume>204</volume><spage>3</spage><epage>13</epage><pages>3-13</pages><issn>1521-6616</issn><eissn>1521-7035</eissn><abstract>•SLAMF6 is a cell surface receptor, expressed only on hematopoietic cells•SLAMF6 receptor can positively or negatively regulate immune responses•SLAMF6 is implicated in autoimmunity and cancer and this receptor can be targeted to help improve current treatment in various diseases.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>30366106</pmid><doi>10.1016/j.clim.2018.10.013</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1521-6616 |
| ispartof | Clinical immunology (Orlando, Fla.), 2019-07, Vol.204, p.3-13 |
| issn | 1521-6616 1521-7035 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2126908547 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Animals Humans Neoplasms - immunology Signaling Lymphocytic Activation Molecule Family - immunology |
| title | SLAMF6 in health and disease: Implications for therapeutic targeting |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T16%3A04%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SLAMF6%20in%20health%20and%20disease:%20Implications%20for%20therapeutic%20targeting&rft.jtitle=Clinical%20immunology%20(Orlando,%20Fla.)&rft.au=Yigit,%20Burcu&rft.date=2019-07&rft.volume=204&rft.spage=3&rft.epage=13&rft.pages=3-13&rft.issn=1521-6616&rft.eissn=1521-7035&rft_id=info:doi/10.1016/j.clim.2018.10.013&rft_dat=%3Cproquest_cross%3E2126908547%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2126908547&rft_id=info:pmid/30366106&rft_els_id=S1521661618304042&rfr_iscdi=true |